• Je něco špatně v tomto záznamu ?

Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy

R. Perone, C. Albertini, E. Uliassi, F. Di Pietri, P. de Sena Murteira Pinheiro, S. Petralla, N. Rizzardi, R. Fato, L. Pulkrabkova, O. Soukup, A. Tramarin, M. Bartolini, ML. Bolognesi

. 2021 ; 16 (1) : 187-198. [pub] 20200831

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026211

Thanks to the widespread use and safety profile of donepezil (1) in the treatment of Alzheimer's disease (AD), one of the most widely adopted multi-target-directed ligand (MTDL) design strategies is to modify its molecular structure by linking a second fragment carrying an additional AD-relevant biological property. Herein, supported by a proposed combination therapy of 1 and the quinone drug idebenone, we rationally designed novel 1-based MTDLs targeting Aβ and oxidative pathways. By exploiting a bioisosteric replacement of the indanone core of 1 with a 1,4-naphthoquinone, we ended up with a series of highly merged derivatives, in principle devoid of the "physicochemical challenge" typical of large hybrid-based MTDLs. A preliminary investigation of their multi-target profile identified 9, which showed a potent and selective butyrylcholinesterase inhibitory activity, together with antioxidant and antiaggregating properties. In addition, it displayed a promising drug-like profile.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026211
003      
CZ-PrNML
005      
20221024081944.0
007      
ta
008      
211013s2021 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cmdc.202000484 $2 doi
035    __
$a (PubMed)32716144
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Perone, Rosaria $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
245    10
$a Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy / $c R. Perone, C. Albertini, E. Uliassi, F. Di Pietri, P. de Sena Murteira Pinheiro, S. Petralla, N. Rizzardi, R. Fato, L. Pulkrabkova, O. Soukup, A. Tramarin, M. Bartolini, ML. Bolognesi
520    9_
$a Thanks to the widespread use and safety profile of donepezil (1) in the treatment of Alzheimer's disease (AD), one of the most widely adopted multi-target-directed ligand (MTDL) design strategies is to modify its molecular structure by linking a second fragment carrying an additional AD-relevant biological property. Herein, supported by a proposed combination therapy of 1 and the quinone drug idebenone, we rationally designed novel 1-based MTDLs targeting Aβ and oxidative pathways. By exploiting a bioisosteric replacement of the indanone core of 1 with a 1,4-naphthoquinone, we ended up with a series of highly merged derivatives, in principle devoid of the "physicochemical challenge" typical of large hybrid-based MTDLs. A preliminary investigation of their multi-target profile identified 9, which showed a potent and selective butyrylcholinesterase inhibitory activity, together with antioxidant and antiaggregating properties. In addition, it displayed a promising drug-like profile.
650    _2
$a acetylcholinesterasa $x chemie $x metabolismus $7 D000110
650    _2
$a Alzheimerova nemoc $x farmakoterapie $7 D000544
650    _2
$a amyloidní beta-protein $x antagonisté a inhibitory $x metabolismus $7 D016229
650    _2
$a antioxidancia $x chemie $x metabolismus $x farmakologie $7 D000975
650    _2
$a hematoencefalická bariéra $x diagnostické zobrazování $x metabolismus $7 D001812
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a cholinesterasové inhibitory $x chemie $x metabolismus $x farmakologie $x terapeutické užití $7 D002800
650    _2
$a donepezil $x chemie $x metabolismus $x farmakologie $x terapeutické užití $7 D000077265
650    _2
$a racionální návrh léčiv $7 D015195
650    _2
$a lidé $7 D006801
650    _2
$a indany $x chemie $7 D007189
650    12
$a ligandy $7 D008024
650    _2
$a neuroprotektivní látky $x chemie $x metabolismus $x farmakologie $x terapeutické užití $7 D018696
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a proteinové agregáty $x účinky léků $7 D066329
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Albertini, Claudia $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
700    1_
$a Uliassi, Elisa $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
700    1_
$a Di Pietri, Flaminia $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
700    1_
$a de Sena Murteira Pinheiro, Pedro $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy $u Programa de Pós-Graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, 21941-902, Rio de Janeiro, RJ, Brazil
700    1_
$a Petralla, Sabrina $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
700    1_
$a Rizzardi, Nicola $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
700    1_
$a Fato, Romana $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
700    1_
$a Pulkrábková, Lenka, $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska, 1575 $d 1993- $7 xx0277918
700    1_
$a Soukup, Ondrej $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic
700    1_
$a Tramarin, Anna $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
700    1_
$a Bartolini, Manuela $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
700    1_
$a Bolognesi, Maria Laura $u Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Belmeloro 6/Via Irnerio 48/Via Selmi 3, 40126, Bologna, Italy
773    0_
$w MED00173270 $t ChemMedChem $x 1860-7187 $g Roč. 16, č. 1 (2021), s. 187-198
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32716144 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20221024081942 $b ABA008
999    __
$a ok $b bmc $g 1715039 $s 1146718
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 16 $c 1 $d 187-198 $e 20200831 $i 1860-7187 $m ChemMedChem $n ChemMedChem $x MED00173270
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

    Možnosti archivace